|
Name |
Penicisteroid B
|
| Molecular Formula | C30H48O4 | |
| IUPAC Name* |
[(3S,8S,9S,10R,11S,13S,14S,16S,17R)-17-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-3,11-dihydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-16-yl] acetate
|
|
| SMILES |
C[C@H](/C=C/[C@H](C)C(C)C)[C@H]1[C@H](C[C@@H]2[C@@]1(C[C@@H]([C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)O)C)OC(=O)C
|
|
| InChI |
InChI=1S/C30H48O4/c1-17(2)18(3)8-9-19(4)27-26(34-20(5)31)15-24-23-11-10-21-14-22(32)12-13-29(21,6)28(23)25(33)16-30(24,27)7/h8-10,17-19,22-28,32-33H,11-16H2,1-7H3/b9-8+/t18-,19+,22-,23-,24-,25-,26-,27-,28+,29-,30-/m0/s1
|
|
| InChIKey |
ASJDHPNJTXZGII-ZVMPSDJMSA-N
|
|
| Synonyms |
Penicisteroid B
|
|
| CAS | NA | |
| PubChem CID | 139588208 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 472.7 | ALogp: | 5.9 |
| HBD: | 2 | HBA: | 4 |
| Rotatable Bonds: | 6 | Lipinski's rule of five: | Rejected |
| Polar Surface Area: | 66.8 | Aromatic Rings: | 4 |
| Heavy Atoms: | 34 | QED Weighted: | 0.38 |
| Caco-2 Permeability: | -4.687 | MDCK Permeability: | 0.00002420 |
| Pgp-inhibitor: | 0.981 | Pgp-substrate: | 0.994 |
| Human Intestinal Absorption (HIA): | 0.142 | 20% Bioavailability (F20%): | 0.31 |
| 30% Bioavailability (F30%): | 0.544 |
| Blood-Brain-Barrier Penetration (BBB): | 0.598 | Plasma Protein Binding (PPB): | 88.00% |
| Volume Distribution (VD): | 1.001 | Fu: | 2.99% |
| CYP1A2-inhibitor: | 0.029 | CYP1A2-substrate: | 0.127 |
| CYP2C19-inhibitor: | 0.017 | CYP2C19-substrate: | 0.88 |
| CYP2C9-inhibitor: | 0.116 | CYP2C9-substrate: | 0.041 |
| CYP2D6-inhibitor: | 0.012 | CYP2D6-substrate: | 0.051 |
| CYP3A4-inhibitor: | 0.842 | CYP3A4-substrate: | 0.691 |
| Clearance (CL): | 3.601 | Half-life (T1/2): | 0.132 |
| hERG Blockers: | 0.11 | Human Hepatotoxicity (H-HT): | 0.309 |
| Drug-inuced Liver Injury (DILI): | 0.285 | AMES Toxicity: | 0.01 |
| Rat Oral Acute Toxicity: | 0.901 | Maximum Recommended Daily Dose: | 0.959 |
| Skin Sensitization: | 0.312 | Carcinogencity: | 0.172 |
| Eye Corrosion: | 0.004 | Eye Irritation: | 0.017 |
| Respiratory Toxicity: | 0.97 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC002021 | ![]() |
0.649 | D0Y7LD | ![]() |
0.400 | ||
| ENC002795 | ![]() |
0.635 | D0B4RU | ![]() |
0.393 | ||
| ENC004758 | ![]() |
0.550 | D0G5CF | ![]() |
0.359 | ||
| ENC001558 | ![]() |
0.550 | D0G8OC | ![]() |
0.354 | ||
| ENC001846 | ![]() |
0.476 | D04SFH | ![]() |
0.345 | ||
| ENC003369 | ![]() |
0.476 | D0K0EK | ![]() |
0.336 | ||
| ENC001545 | ![]() |
0.471 | D06JPB | ![]() |
0.333 | ||
| ENC005012 | ![]() |
0.467 | D0X7XG | ![]() |
0.308 | ||
| ENC004738 | ![]() |
0.445 | D06CNP | ![]() |
0.296 | ||
| ENC001092 | ![]() |
0.445 | D02STN | ![]() |
0.285 | ||